Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anita Wary"'
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Rationale and Goal: Endothelial cells (ECs) are quiescent and critical for maintaining homeostatic functions of the mature vascular system, while disruption of quiescence is at the heart of endothelial to mesenchymal transition (EndMT) and tumor angi
Externí odkaz:
https://doaj.org/article/70983a8732bf49e1b9d34475b17752b1
Autor:
Kundan Solanki, Sajjan Rajpoot, Evgeny E. Bezsonov, Alexander N. Orekhov, Rohit Saluja, Anita Wary, Cassondra Axen, Kishore Wary, Mirza S. Baig
Publikováno v:
PeerJ, Vol 10, p e13651 (2022)
The nitric oxide synthases (NOS; EC 1.14.13.39) use L-arginine as a substrate to produce nitric oxide (NO) as a by-product in the tissue microenvironment. NOS1 represents the predominant NO-producing enzyme highly enriched in the brain and known to m
Externí odkaz:
https://doaj.org/article/7581a9b1ac83482bb68978991cec3a7a
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176496 (2017)
The human epigenome is plastic. The goal of this study was to address if fibroblast cells can be epigenetically modified to promote neovessel formation.Here, we used highly abundant human adult dermal fibroblast cells (hADFCs) that were treated with
Externí odkaz:
https://doaj.org/article/e3bf07ba78ea41bfb2fdac7638c796c5
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176496 (2017)
PLoS ONE
PLoS ONE
RATIONALE The human epigenome is plastic. The goal of this study was to address if fibroblast cells can be epigenetically modified to promote neovessel formation. METHODS AND RESULTS Here, we used highly abundant human adult dermal fibroblast cells (
Autor:
Anita Wary
Publikováno v:
Cancer Research. 78:1374-1374
The ability of genome editing tool to correct genetic disease, or edit the tumor causing gene, will not only benefit human race, but also plants and animal kingdom. The CRISPR/Cas9 system can be used to target specific genomic loci by single guide RN
Autor:
Anita Wary
Publikováno v:
Cancer Research. 78:2046-2046
The vascular endothelial growth factor receptor-2 (VEGFR2) is a receptor tyrosine kinase that is expressed highly in endothelial cells (ECs). By binding to VEGF165 (VEGF-A) VEGFR2 signals in ECs mediate the formation of new blood vessels, a process k